Chi‐Li Chung

1.7k total citations
76 papers, 1.1k citations indexed

About

Chi‐Li Chung is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Chi‐Li Chung has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Chi‐Li Chung's work include Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (12 papers) and Pleural and Pulmonary Diseases (12 papers). Chi‐Li Chung is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Treatments and Mutations (12 papers) and Pleural and Pulmonary Diseases (12 papers). Chi‐Li Chung collaborates with scholars based in Taiwan, United States and India. Chi‐Li Chung's co-authors include Joen‐Rong Sheu, George Hsiao, Shi-Chuan Chang, Shih-Hsin Hsiao, Jer‐Hwa Chang, Sey‐En Lin, Yu‐Ting Chou, Ming‐Hsien Chien, Wan‐Jung Lu and Wei-Lin Chen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Chi‐Li Chung

73 papers receiving 1.1k citations

Peers

Chi‐Li Chung
Dae‐Woon Eom South Korea
Murali K. Ankem United States
Nir I. Weijl Netherlands
Li Zhong China
Paul C. Armstrong United Kingdom
Chi‐Li Chung
Citations per year, relative to Chi‐Li Chung Chi‐Li Chung (= 1×) peers Marta Prieto

Countries citing papers authored by Chi‐Li Chung

Since Specialization
Citations

This map shows the geographic impact of Chi‐Li Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Li Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Li Chung more than expected).

Fields of papers citing papers by Chi‐Li Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Li Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Li Chung. The network helps show where Chi‐Li Chung may publish in the future.

Co-authorship network of co-authors of Chi‐Li Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Li Chung. A scholar is included among the top collaborators of Chi‐Li Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Li Chung. Chi‐Li Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sheu, Joen‐Rong, et al.. (2023). Ability of Local Clearance of Senescent Cells in Ipsilateral Hemisphere to Mitigate Acute Ischemic Brain Injury in Mice. International Journal of Biological Sciences. 19(9). 2835–2847. 14 indexed citations
2.
Lai, Tsung‐Ching, Yu-Chieh Chen, Yi‐Chieh Yang, et al.. (2023). Sustaining the Activation of EGFR Signal by Inflammatory Cytokine IL17A Prompts Cell Proliferation and EGFR-TKI Resistance in Lung Cancer. Cancers. 15(13). 3288–3288. 5 indexed citations
3.
Chen, Weilin, et al.. (2023). Toll-like Receptor 2 Mediates VEGF Overexpression and Mesothelial Hyperpermeability in Tuberculous Pleural Effusion. International Journal of Molecular Sciences. 24(3). 2846–2846. 3 indexed citations
4.
5.
Tsai, Jo‐Ting, Her‐Shyong Shiah, Hsuan‐Yu Chen, et al.. (2023). Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and Oligoprogression. Diagnostics. 13(9). 1597–1597. 1 indexed citations
6.
Chen, Wan‐Ting, Chi‐Li Chung, Yu‐Ting Chou, et al.. (2022). Comparative survival analysis of platinum‐based adjuvant chemotherapy for early‐stage squamous cell carcinoma and adenocarcinoma of the lung. Cancer Medicine. 11(10). 2067–2078. 13 indexed citations
7.
Wu, Ming‐Ping, Chih‐Wei Hsia, Thanasekaran Jayakumar, et al.. (2022). Decreased Human Platelet Activation and Mouse Pulmonary Thrombosis by Rutaecarpine and Comparison of the Relative Effectiveness with BAY11-7082: Crucial Signals of p38-NF-κB. Molecules. 27(2). 476–476. 7 indexed citations
8.
Chung, Chi‐Li, et al.. (2022). Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and Mice. International Journal of Molecular Sciences. 23(19). 11372–11372. 13 indexed citations
9.
Hsia, Chih‐Wei, et al.. (2020). Regulation of Human Platelet Activation and Prevention of Arterial Thrombosis in Mice by Auraptene through Inhibition of NF-κB Pathway. International Journal of Molecular Sciences. 21(13). 4810–4810. 9 indexed citations
10.
Lee, Hsin‐Lun, Jeng-Fong Chiou, Peng‐Yuan Wang, et al.. (2020). Ex Vivo Expansion and Drug Sensitivity Profiling of Circulating Tumor Cells from Patients with Small Cell Lung Cancer. Cancers. 12(11). 3394–3394. 33 indexed citations
11.
Lien, Jin‐Cherng, et al.. (2019). A novel 2‐aminobenzimidazole‐based compound Jzu 17 exhibits anti‐angiogenesis effects by targeting VEGFR‐2 signalling. British Journal of Pharmacology. 176(20). 4034–4049. 19 indexed citations
12.
Hsieh, Cheng‐Ying, et al.. (2019). Endothelin-1 Induces Mesothelial Mesenchymal Transition and Correlates with Pleural Fibrosis in Tuberculous Pleural Effusions. Journal of Clinical Medicine. 8(4). 426–426. 1 indexed citations
13.
Hsieh, Cheng-Ying, et al.. (2019). Thrombin Upregulates PAI-1 and Mesothelial–Mesenchymal Transition Through PAR-1 and Contributes to Tuberculous Pleural Fibrosis. International Journal of Molecular Sciences. 20(20). 5076–5076. 6 indexed citations
14.
Yen, Ting‐Lin, Chao-Chien Chang, Chi‐Li Chung, et al.. (2018). Neuroprotective Effects of Platonin, a Therapeutic Immunomodulating Medicine, on Traumatic Brain Injury in Mice after Controlled Cortical Impact. International Journal of Molecular Sciences. 19(4). 1100–1100. 16 indexed citations
15.
Chang, Chuen‐Chau, Ta-Liang Chen, Chao‐Shun Lin, et al.. (2018). Decreased risk of pneumonia in stroke patients receiving acupuncture: A nationwide matched-pair retrospective cohort study. PLoS ONE. 13(5). e0196094–e0196094. 14 indexed citations
16.
Jayakumar, Thanasekaran, Joen‐Rong Sheu, Marappan Velusamy, et al.. (2018). Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets. Molecules. 23(2). 477–477. 5 indexed citations
17.
Lin, Chao‐Shun, Chun-Chieh Yeh, Yi‐Cheng Chang, et al.. (2017). Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: Two nationwide population-based retrospective cohort studies. PLoS ONE. 12(8). e0181815–e0181815. 20 indexed citations
18.
Chung, Chi‐Li, et al.. (2017). Lupus pneumonitis presenting with high titre of anti‐Ro antibody. Respirology Case Reports. 6(1). e00280–e00280. 2 indexed citations
19.
Chen, Weilin, et al.. (2017). Lipoteichoic acid upregulates plasminogen activator inhibitor‐1 expression in parapneumonic effusions. Respirology. 23(1). 89–95. 7 indexed citations
20.
Chung, Chi‐Li & R.-P. Perng. (1996). Thymic cyst: a case report. Clinical Medicine. 37. 63–64.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026